The aftermath of COVID-19 in dermatology practice: What's next?
Janice Natasha C NgKathryn Anne Guico CembranoRungsima WanitphakdeedechaWoraphong ManuskiattiPublished in: Journal of cosmetic dermatology (2020)
The rapidly increasing number of COVID-19-infected patients and evidence of human-to-human transmission even within the asymptomatic incubation period prompted the attention of the entire world. The field of dermatology and procedural dermatology is not exempt from this global issue. We cannot deny the fact that this situation will have a lasting impact on the health-seeking behaviors of our patients. It is necessary for dermatologists and dermatologic surgeons to be aware of the potential risks and precautions when re-emerging their practices after COVID-19.
Keyphrases
- coronavirus disease
- sars cov
- endothelial cells
- healthcare
- end stage renal disease
- primary care
- induced pluripotent stem cells
- newly diagnosed
- human health
- public health
- chronic kidney disease
- ejection fraction
- pluripotent stem cells
- quality improvement
- peritoneal dialysis
- working memory
- risk assessment
- climate change